These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 17006922
1. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage. Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R, Remondini E, Trombini P, Fargion S. Hepatology; 2006 Oct; 44(4):857-64. PubMed ID: 17006922 [Abstract] [Full Text] [Related]
2. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. Valenti L, Canavesi E, Galmozzi E, Dongiovanni P, Rametta R, Maggioni P, Maggioni M, Fracanzani AL, Fargion S. J Hepatol; 2010 Nov; 53(5):927-33. PubMed ID: 20739079 [Abstract] [Full Text] [Related]
3. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S. Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316 [Abstract] [Full Text] [Related]
4. Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse? Schmechel DE. Neurotoxicology; 2007 Sep; 28(5):899-914. PubMed ID: 17659342 [Abstract] [Full Text] [Related]
5. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. Regev A, Guaqueta C, Molina EG, Conrad A, Mishra V, Brantly ML, Torres M, De Medina M, Tzakis AG, Schiff ER. J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398 [Abstract] [Full Text] [Related]
6. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Aigner E, Theurl I, Haufe H, Seifert M, Hohla F, Scharinger L, Stickel F, Mourlane F, Weiss G, Datz C. Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688 [Abstract] [Full Text] [Related]
7. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. Lecube A, Hernández C, Simó R. Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865 [Abstract] [Full Text] [Related]
9. Mild Iron Overload as Seen in Individuals Homozygous for the Alpha-1 Antitrypsin Pi*Z Variant Does Not Promote Liver Fibrogenesis in HFE Knockout Mice. Guldiken N, Hamesch K, Schuller SM, Aly M, Lindhauer C, Schneider CV, Fromme M, Trautwein C, Strnad P. Cells; 2019 Nov 09; 8(11):. PubMed ID: 31717526 [Abstract] [Full Text] [Related]
10. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Bugianesi E, Manzini P, D'Antico S, Vanni E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G, Rizzetto M. Hepatology; 2004 Jan 09; 39(1):179-87. PubMed ID: 14752836 [Abstract] [Full Text] [Related]
11. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J. Hepatology; 2006 Dec 09; 44(6):1648-55. PubMed ID: 17133473 [Abstract] [Full Text] [Related]
12. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Mishra P, Nugent C, Afendy A, Bai C, Bhatia P, Afendy M, Fang Y, Elariny H, Goodman Z, Younossi ZM. Liver Int; 2008 Sep 09; 28(8):1080-6. PubMed ID: 18647236 [Abstract] [Full Text] [Related]
13. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload? de Diego C, Opazo S, Murga MJ, Martínez-Castro P. Eur J Haematol; 2007 Jan 09; 78(1):66-71. PubMed ID: 17042772 [Abstract] [Full Text] [Related]
14. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Miyaaki H, Ichikawa T, Nakao K, Yatsuhashi H, Furukawa R, Ohba K, Omagari K, Kusumoto Y, Yanagi K, Inoue O, Kinoshita N, Ishibashi H, Yano M, Eguchi K. Liver Int; 2008 Apr 09; 28(4):519-24. PubMed ID: 17976158 [Abstract] [Full Text] [Related]